AFC Gamma, Inc. Schedules First Quarter 2024 Earnings Conference Call for May 9, 2024
WEST PALM BEACH, Fla., April 10, 2024 (GLOBE NEWSWIRE) — AFC Gamma, Inc. (NASDAQ:AFCG) (“AFC Gamma”) today announced that it […]
WEST PALM BEACH, Fla., April 10, 2024 (GLOBE NEWSWIRE) — AFC Gamma, Inc. (NASDAQ:AFCG) (“AFC Gamma”) today announced that it […]
VANCOUVER, British Columbia, April 10, 2024 (GLOBE NEWSWIRE) — Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neurology-focused biopharmaceutical company, today announced that […]
TYSONS CORNER, Va. and PETAH TIKVA, Israel, April 10, 2024 (GLOBE NEWSWIRE) — Cellebrite (NASDAQ: CLBT), a global leader in […]
Mr. Jurvetson is a legendary investor focused on founder-led, mission-driven companies at the cutting edge of disruptive technology and new […]
GLEN ALLEN, Va., April 10, 2024 (GLOBE NEWSWIRE) — Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage […]
Nanjing, China, April 10, 2024 (GLOBE NEWSWIRE) — Ostin Technology Group Co., Ltd. (“the Company”) (Nasdaq: OST), a leading supplier […]
FREMONT, CA, April 10, 2024 (GLOBE NEWSWIRE) — via NewMediaWire — ABVC BioPharma, Inc. (NASDAQ: ABVC) (“Company”), a clinical-stage biopharmaceutical company [...]
HOUSTON, April 10, 2024 (GLOBE NEWSWIRE) — Nexalin Technology, Inc. (the “Company” or “Nexalin”) (Nasdaq: NXL; NXLIW) today provided the […]
HERNDON, Va., April 10, 2024 (GLOBE NEWSWIRE) — Navient (Nasdaq: NAVI), a leader in technology-enabled education finance and business processing […]
– PALI-2108 in development for the treatment of moderate-to-severe ulcerative colitis (UC) advancing towards Phase 1 clinical study before year […]